An antiviral prescription can be used in different ways. Episodic treatment is started around a recognized outbreak; suppressive treatment is taken regularly to reduce recurrences in selected patients. The right approach depends on the infection and its effect on your life, not simply whether a tablet can be purchased in a larger pack.
At AV Community Clinic, we review the diagnosis, outbreak history, kidney health and treatment goals before recommending a strategy. We can discuss an established plan, help assess a change in the pattern and coordinate medication supply when appropriate. The plan remains open to review as your circumstances change.
Make sure the diagnosis is clear
Cold sores, genital herpes and shingles are different treatment settings. A regimen intended for one should not be reused for another. Some mouth ulcers and genital lesions have another cause, so a first or uncertain episode may need examination or testing before an antiviral plan is established.
For genital herpes, the viral type and recurrence pattern can influence the discussion. Genital HSV-1 often has a different recurrence pattern from HSV-2, but an individual history still matters. We use test information when available and do not infer the diagnosis or future burden solely from appearance.
Pregnancy, reduced immunity, severe illness or eye involvement requires particular attention. These situations may need maternity, specialist or urgent care rather than a routine choice between daily and episodic tablets. Tell us about those circumstances before using a previously issued supply.
Comparing the treatment strategies
| Question | Episodic treatment | Daily suppression |
|---|---|---|
| When medicine is taken | At the recognized symptoms specified in the plan | On a regular prescribed schedule |
| Main goal | Manage the current recurrence | Reduce future recurrences and their burden |
| Practical requirement | Recognize the episode and have timely access to the correct course | Maintain regular use and periodic review |
| A reason to discuss it | Occasional episodes that can be managed with a clear early-treatment plan | Frequent, troublesome or distressing recurrences in an appropriate setting |
| What it does not mean | The virus has been removed after the course | Outbreaks and transmission are impossible |
The two strategies use different regimens. Do not turn an episodic prescription into suppression by taking leftover tablets every day, or treat a breakthrough episode by adding an unreviewed course on top of regular treatment.
What makes an episodic plan useful
Prompt treatment is important for recognized recurrent genital herpes, often at the prodrome or soon after lesions begin according to the agreed instructions. An advance supply or prescription may help when the diagnosis is established. The useful part is the clear plan, not simply having tablets available.
We explain which symptoms it covers, the exact course and what to do if the episode differs from usual. Keep those instructions with the medicine. A rash near the eye, severe pain, urinary difficulty or a new illness should not automatically follow an old routine designed for an uncomplicated recurrence.
Tell us whether access or uncertainty has delayed earlier courses. If treatment repeatedly begins too late or the pattern is hard to recognize, that may influence the strategy. We can review practical barriers as well as the medicine choice rather than assume another pack resolves the issue.
When daily suppression deserves discussion
The number of episodes is one consideration, but their severity, duration, emotional burden and effect on relationships or daily activities also matters. Some people want fewer disruptive recurrences; others prefer a short-course approach. The decision should reflect those priorities and a clear clinical indication.
We review the expected benefit, daily routine, kidney considerations and other medicines. Suppression is reassessed periodically rather than treated as permanent by default. An absence of outbreaks while taking it may reflect benefit, but future decisions still need discussion of the original pattern and current preferences.
Breakthrough lesions do not automatically mean the dose should be increased. Missed treatment, another diagnosis or a change in immune health may need review. Persistent or unusual symptoms require assessment rather than a series of self-directed antiviral adjustments.
Transmission is a separate conversation
Neither approach guarantees that herpes cannot be transmitted. Avoid sexual contact during lesions or warning symptoms and discuss condoms and other precautions. Viral shedding can occur without visible lesions, so absence of an outbreak is not a complete measure of risk.
Daily valacyclovir has transmission-reduction evidence in selected circumstances, but that benefit should not be generalized to every medicine, infection or patient. Reducing outbreaks and reducing transmission are related but distinct goals. We discuss what the evidence means for the actual plan rather than promise that daily tablets make contact safe.
For cold sores, avoid kissing or sharing items that contact active lesions and take care around infants or people with reduced immunity. Starting an antiviral does not immediately remove those precautions. Wash hands after touching the affected area and avoid contact with the eyes.
What to bring to your consultation
- Previous diagnostic results or details of where the diagnosis was made.
- A record of recurrences, including severity and effect on daily life.
- The antiviral, strength, schedule and response used previously.
- Kidney history, current medicines and recent illness or dehydration.
- Pregnancy or breastfeeding information and immune-suppressing treatment.
- Your main goal, including outbreak control, convenience or questions about transmission.
You can also raise concerns about stigma, disclosure or uncertainty. Those are legitimate parts of care. A useful consultation should address what the diagnosis means to you rather than focus only on which pack is easiest to supply.
Safety and follow-up
Valacyclovir, famciclovir and acyclovir have different regimens and may need kidney-adjusted dosing. Do not exchange them tablet for tablet. Significant dehydration, reduced urine, severe weakness or new confusion needs assessment, particularly in someone with kidney disease or other vulnerabilities.
Contact us if lesions persist after treatment, look different or become unusually frequent or severe. Another diagnosis or complication may need investigation. A daily or episodic prescription should not repeatedly postpone an examination when the clinical picture changes.
Selected established care can be reviewed online, while first episodes, pregnancy-related concerns or complicated symptoms may need another setting. When an antiviral plan is appropriate, we confirm the medicine, supply, review and clear instructions for symptoms that fall outside the usual pattern.
Common questions
Is suppression only for people with very frequent episodes?
Frequency matters, but severity, distress and other circumstances can also influence the discussion. We review the diagnosis and goals before deciding whether daily treatment is appropriate. There is no single episode count that replaces an individual assessment.
Can daily treatment be reviewed later?
Yes. The need can be reassessed as the recurrence pattern, health and preferences change. A future reduction or switch to episodic treatment should be discussed so that you know what to do if symptoms return rather than stop without a plan.
Does no visible outbreak mean no transmission risk?
No. Shedding can occur without obvious lesions, and treatment does not remove all risk. We discuss precautions and the limits of any medicine-specific transmission benefit rather than treat appearance alone as proof of safety.